Antiviral Ranpirnase TMR-001 Inhibits Rabies Virus Release and Cell-to-Cell Infection In Vitro
Currently, no rabies virus-specific antiviral drugs are available.Ranpirnase has strong antitumor and antiviral properties associated with its ribonuclease activity.TMR-001, a proprietary bulk drug substance solution of ranpirnase, was evaluated against rabies virus in three cell types: s2720 mouse neuroblastoma, BSR (baby hamster kidney cells), an